Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Phathom Pharmaceuticals Stock News

PHATNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$2.76

-0.60-17.86%

At close: -

$2.80

0.041.45%

After Hours: May 2, 7:58 PM EDT

Q1 2025 Earnings were released on Thu May 1st, before the market open

The most recent conference call was at 8:30 AM, 3 days ago Click to view past webcast

Phathom Pharmaceuticals (PHAT) Forecast

News

Earnings Phathom Pharmaceuticals (PHAT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Phathom Pharmaceuticals Stock News | NASDAQ:PHAT | Benzinga

Get the latest news on Phathom Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Phathom Pharmaceuticals performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, May 02, 2025

Goldman Sachs Maintains Neutral on Phathom Ph...
Benzinga Newsdesk - 2 days ago
Guggenheim Maintains Buy on Phathom Pharmaceu...
Benzinga Newsdesk - 2 days ago
Phathom Pharmaceuticals shares are trading lo...
Benzinga Newsdesk - 2 days ago
HC Wainwright & Co. Maintains Buy on Phathom ...
Benzinga Newsdesk - 2 days ago

Thursday, May 01, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - 3 days ago
Phathom Pharmaceuticals shares are trading lo...
Benzinga Newsdesk - 3 days ago
UPDATE: Phathom Pharmaceuticals Q1 Adj. EPS $...
Benzinga Newsdesk - 3 days ago
Phathom Pharmaceuticals Q1 EPS $(1.31) Misses...
Benzinga Newsdesk - 3 days ago
Earnings Scheduled For May 1, 2025
Benzinga Insights - 3 days ago

Wednesday, April 30, 2025

Insights Ahead: Phathom Pharmaceuticals's Quarterly Earnings
Benzinga Insights - 4 days ago

Monday, April 28, 2025

Phathom to Showcase Real-World Data for VOQUE...
Benzinga Newsdesk - 6 days ago

Monday, April 21, 2025

Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Apr 21, 2025, 7:24AM

Thursday, April 17, 2025

Goldman Sachs Maintains Neutral on Phathom Ph...
Benzinga Newsdesk - Apr 17, 2025, 1:43PM

Wednesday, April 09, 2025

Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Apr 9, 2025, 8:05AM

Wednesday, April 02, 2025

Guggenheim Reiterates Buy on Phathom Pharmace...
Benzinga Newsdesk - Apr 2, 2025, 11:48AM
Phathom Pharmaceuticals shares are trading hi...
Benzinga Newsdesk - Apr 2, 2025, 10:44AM
Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Apr 2, 2025, 8:02AM

Monday, March 31, 2025

Kenan Thompson Teams Up with Phathom to Raise...
Benzinga Newsdesk - Mar 31, 2025, 8:05AM

Tuesday, March 18, 2025

Phathom Pharmaceuticals shares are trading hi...
Benzinga Newsdesk - Mar 18, 2025, 1:31PM
Form4 Shows Phathom Pharmaceuticals Director ...
Benzinga Newsdesk - Mar 18, 2025, 1:24PM
IHS Holding Posts Upbeat Earnings, Joins Tencent Music Entertainment, Elbit Systems And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor - Mar 18, 2025, 11:15AM

Monday, March 10, 2025

Goldman Sachs Maintains Neutral on Phathom Ph...
Benzinga Newsdesk - Mar 10, 2025, 1:36PM

Friday, March 07, 2025

HC Wainwright & Co. Reiterates Buy on Phathom...
Benzinga Newsdesk - Mar 7, 2025, 6:52AM

Thursday, March 06, 2025

Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Mar 6, 2025, 2:08PM
Phathom Pharmaceuticals Q4 Adj $(0.79) Beats ...
Benzinga Newsdesk - Mar 6, 2025, 8:08AM
Earnings Scheduled For March 6, 2025
Benzinga Insights - Mar 6, 2025, 3:32AM

Friday, January 10, 2025

Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Jan 10, 2025, 7:41AM

Thursday, December 12, 2024

HC Wainwright & Co. Reiterates Buy on Phathom...
Benzinga Newsdesk - Dec 12, 2024, 6:33AM

Wednesday, December 11, 2024

Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Dec 11, 2024, 1:12PM
Phathom Pharmaceuticals Submits Citizen Petit...
Benzinga Newsdesk - Dec 11, 2024, 8:05AM

Thursday, November 07, 2024

Phathom Pharmaceuticals Q3 2024 Adj. EPS $(1....
Benzinga Newsdesk - Nov 7, 2024, 8:04AM

Monday, October 28, 2024

Reported Earlier, Phathom Pharmaceuticals To ...
Benzinga Newsdesk - Oct 28, 2024, 3:32AM

Thursday, October 03, 2024

12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights - Oct 3, 2024, 4:31PM

Friday, September 13, 2024

Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Sep 13, 2024, 11:41AM

Friday, September 06, 2024

Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Sep 6, 2024, 1:14PM

Friday, August 30, 2024

Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Aug 30, 2024, 12:07PM

Friday, August 23, 2024

Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Aug 23, 2024, 1:20PM

Monday, August 19, 2024

Phathom Pharmaceuticals Prices Offering Of 8....
Benzinga Newsdesk - Aug 19, 2024, 8:02AM
Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Aug 19, 2024, 5:37AM

Monday, August 12, 2024

HC Wainwright & Co. Reiterates Buy on Phathom...
Benzinga Newsdesk - Aug 12, 2024, 6:00AM
Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Aug 12, 2024, 5:48AM

Friday, August 09, 2024

Goldman Sachs Maintains Neutral on Phathom Ph...
Benzinga Newsdesk - Aug 9, 2024, 11:49AM

Thursday, August 08, 2024

As Of June 30, 2024, Phathom Pharmaceuticals'...
Benzinga Newsdesk - Aug 8, 2024, 8:07AM
Phathom Pharmaceuticals Q2 2024 Adj. EPS $(1....
Benzinga Newsdesk - Aug 8, 2024, 8:06AM

Tuesday, July 30, 2024

CVS Caremark Adds VOQUEZNA Tablets To Nationa...
Benzinga Newsdesk - Jul 30, 2024, 8:11AM

Friday, July 26, 2024

Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Jul 26, 2024, 6:22AM

Monday, July 22, 2024

Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Jul 22, 2024, 8:20AM

Friday, July 19, 2024

HC Wainwright & Co. Reiterates Buy on Phathom...
Benzinga Newsdesk - Jul 19, 2024, 6:41AM
Needham Reiterates Buy on Phathom Pharmaceuti...
Benzinga Newsdesk - Jul 19, 2024, 5:48AM

Thursday, July 18, 2024

The FDA Approved Phathom Pharmaceuticals' Voq...
Benzinga Newsdesk - Jul 18, 2024, 8:10AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved